Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Did you mean category antidepressive agent azd group approved?
Displaying drugs 1 - 25 of 8596 in total

Meningococcal polysaccharide vaccine group A

Meningococcal group A polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup A. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup A.
Approved
Experimental
Investigational
Matched Synonyms: … Meningococcal group A polysaccharide ... Meningococcal polysaccharide antigen group A ... Neisseria meningitidis group A polysaccharide antigen, A …
Matched Name: … Meningococcal polysaccharide vaccine group A …
Matched Description: … Meningococcal group A polysaccharide is group-specific polysaccharide antigens extracted and purified …

Meningococcal polysaccharide vaccine group C

Meningococcal group C polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup C. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup C.
Approved
Experimental
Investigational
Matched Synonyms: … Meningococcal group C polysaccharide ... Meningococcal group CCRM197 conjugate vaccine ... Meningococcal polysaccharide antigen group C …
Matched Name: … Meningococcal polysaccharide vaccine group C …
Matched Description: … Meningococcal group C polysaccharide is group-specific polysaccharide antigens extracted and purified …

Meningococcal polysaccharide vaccine group W-135

Meningococcal group W-135 polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup W-135. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup W-135.
Approved
Experimental
Investigational
Matched Synonyms: … Meningococcal polysaccharide antigen group W-135 ... Neisseria meningitidis group W-135 polysaccharide antigen, A ... neisseria meningitidis group W-135 capsular polysaccharide antigen …
Matched Name: … Meningococcal polysaccharide vaccine group W-135 …
Matched Description: … Meningococcal group W-135 polysaccharide is group-specific polysaccharide antigens extracted and purified …

Neisseria meningitidis group Y capsular polysaccharide tetanus toxoid conjugate antigen

Approved
Matched Synonyms: … Nimenrix component neisseria meningitidis group Y capsular polysaccharide tetanus toxoid conjugate antigen …
Matched Name: … Neisseria meningitidis group Y capsular polysaccharide tetanus toxoid conjugate antigen …

Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen

Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen is an active intramuscular immunization for the prophylaxis of invasive meningococcal disease caused by Neisseria meningitidis serogroup a. The vaccine contains N. meningitis serogroup a capsular polysaccharide antigens that are purified and individually conjugated to diphtheria toxoid protein that are...
Approved
Investigational
Matched Name: … Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen …
Matched Description: … Neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen is an active …

Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen

Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen is an active intramuscular immunization for the prophylaxis of invasive meningococcal disease caused by Neisseria meningitidis serogroup W-135. The vaccine contains* N. meningitis* serogroup y capsular polysaccharide antigens that are purified and individually conjugated to diphtheria toxoid protein that are...
Approved
Matched Name: … Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen …
Matched Description: … Neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen is an active …

Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen

Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen is a vaccine.
Approved
Matched Name: … Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen …
Matched Description: … Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen is …

Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen

Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen is an active intramuscular immunization for the prophylaxis of invasive meningococcal disease caused by Neisseria meningitidis serogroup W-135. The vaccine contains N. meningitis serogroup W-135 capsular polysaccharide antigens that are purified and individually conjugated to diphtheria toxoid protein that are...
Approved
Matched Name: … Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen …
Matched Description: … Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen is an …

AstraZeneca COVID-19 Vaccine

The AstraZeneca COVID-19 Vaccine (previously known as ChAdOx1 nCoV-19 or AZD1222) is one of several vaccines developed in 2020 for the prevention of COVID-19 caused by SARS-CoV-2.[L12669,L32649] The ChAdOx1 viral vector was developed at the University of Oxford and has been investigated as a potential vector for vaccines against another...
Approved
Investigational
Matched Synonyms: … AZD-1222 …

Talquetamab

Talquetamab is a IgG4-PAA bispecific G protein-coupled receptor class C group 5 member D (GPRC5D)-directed CD3 T-cell engager. It consists of two arms - anti-GPRC5D and anti-CD3 arms - linked by two interchain disulfide bonds, each arm comprising a heavy and light chain. Talquetamab binds to GPRC5D, a cell surface...
Approved
Investigational
Matched Synonyms: … IMMUNOGLOBULIN G4-KAPPA/G4-LAMBDA, ANTI-(HOMO SAPIENS GPRC5D (G PROTEIN-COUPLED RECEPTOR CLASS C GROUP ... IMMUNOGLOBULIN G4-KAPPA/G4-LAMBDA, ANTI-(HOMO SAPIENS GPRC5D (G PROTEIN-COUPLED RECEPTOR CLASS C GROUP …
Matched Description: … [L47775] Talquetamab was fully approved by the EMA on August 22, 2023. ... Talquetamab is a IgG4-PAA bispecific G protein-coupled receptor class C group 5 member D (GPRC5D)-directed …

Plasma protein fraction (human)

The plasma protein fraction human (PPFh) is defined as a sterile solution of proteins composed mainly of albumin and globulin derived from human plasma. It is already reviewed under the category of biologics by the FDA where the processing, required tests, requirements and labeling are incorporated. This biologic should come...
Approved
Matched Description: … [A32512] It is already reviewed under the category of biologics by the FDA where the processing, required …
Matched Categories: … Hematologic Agents …
Matched Products: … OCTAPLAS Blood Group A ... OCTAPLAS Blood Group O ... OCTAPLAS Blood Group B …

Revefenacin

Revefenacin is a novel biphenyl carbamate tertiary amine agent that belongs to the family of the long-acting muscarinic antagonists (LAMA). The labile primary amide in the structure produces a "soft-drug" site that allows rapid systemic clearance and minimizing of the systemically mediated adverse reactions. The LAMA group falls into a...
Approved
Investigational
Matched Description: … The LAMA group falls into a parent category known as long-acting inhaled bronchodilators and this type ... [A40026] It was developed by Theravance Biopharma and FDA approved on November 9, 2018.[L4818] ... of agents are recommended as a maintenance therapy for chronic obstructive pulmonary disease (COPD). …
Matched Categories: … Anticholinergic Agents ... Bronchodilator Agents …

Acenocoumarol

Acenocoumarol is a coumarin derivative used as an anticoagulant. Coumarin derivatives inhibit the reduction of vitamin K by vitamin K reductase. This prevents carboxylation of vitamin K-dependent clotting factors, II, VII, IX and X, and interferes with coagulation. Hematocrit, hemoglobin, international normalized ratio and liver panel should be monitored. Patients...
Approved
Investigational
Matched Categories: … Hematologic Agents …
Matched Products: … Truemed Group LLC …

Fludrocortisone

Fludrocortisone is a synthetic mineralocorticoid used in conjunction with hydrocortisone to replace missing endogenous corticosteroids in patients with adrenal insufficiency.[A187169,A187187] It is functionally similar to aldosterone, the body's primary endogenous mineralocorticoid, and is structurally analogous to cortisol, differing only by a fluorine atom at the 9-position of the steroid structure...
Approved
Investigational
Matched Categories: … Anti-Inflammatory Agents ... Immunosuppressive Agents ... Hyperglycemia-Associated Agents …
Matched Products: … Truemed Group LLC …

Orciprenaline

A beta-adrenergic agonist used in the treatment of asthma and bronchospasms. [PubChem]
Approved
Matched Categories: … Adrenergic Agents ... Autonomic Agents ... Tocolytic Agents ... Anti-Asthmatic Agents ... Bronchodilator Agents …
Matched Products: … Truemed Group LLC …

Digoxin

Digoxin is one of the oldest cardiovascular medications used today. It is a common agent used to manage atrial fibrillation and the symptoms of heart failure. Digoxin is classified as a cardiac glycoside and was initially approved by the FDA in 1954. This drug originates from the foxglove plant, also...
Approved
Matched Description: … [A178234] Digoxin is classified as a cardiac glycoside and was initially approved by the FDA in 1954. …
Matched Categories: … Antiarrhythmic agents ... Cardiotonic Agents ... Protective Agents ... Agents causing hyperkalemia ... Cardiovascular Agents …
Matched Products: … Truemed Group LLC …

Ioxilan

Ioxilan is a tri-iodinated diagnostic contrast agent. Intravascular injection results in opacification of vessels in the path of flow of the contrast medium, permitting radiographic visualization of the internal structures of the human body until significant hemodilution occurs.
Approved
Matched Categories: … Iodinated Contrast Agents …

Ivermectin

Ivermectin is a semi-synthetic antiparasitic medication derived from avermectins, a class of highly-active broad-spectrum antiparasitic agents isolated from the fermentation products of Streptomyces avermitilis. Ivermectin itself is a mixture of two avermectins, comprising roughly 90% 5-O-demethyl-22,23-dihydroavermectin A1a (22,23-dihydroavermectin B1a) and 10% 5-O-demethyl-25-de(1-methylpropyl)-22,23-dihydro­-25-(1-methylethyl)avermectin A1a (22,23-dihydroavermectin B1b). Ivermectin is mainly used in...
Approved
Investigational
Vet approved
Matched Description: … antiparasitic medication derived from avermectins, a class of highly-active broad-spectrum antiparasitic agents …
Matched Categories: … Antinematodal Agents ... Anti-Infective Agents ... Antiparasitic Agents ... Agents Causing Muscle Toxicity …

Fremanezumab

Fremanezumab is a humanized monoclonal antibody targeted against human calcitonin gene-related peptide (CGRP) for the prevention of migraine headaches. It was developed by Teva Pharmaceuticals USA and approved by the FDA in September 2018. Along with other recently approved anti-CGRP therapies such as galcanezumab, erenumab, and the oral CGRP antagonist...
Approved
Investigational
Matched Description: … [L11749] It was developed by Teva Pharmaceuticals USA and approved by the FDA in September 2018. ... [L11779] Along with other recently approved anti-CGRP therapies such as [galcanezumab], [erenumab], and …

Casirivimab

Casirivimab is a monoclonal antibody combined with Imdevimab in Regeneron's antibody cocktail known as REGN-COV2 for the treatment of COVID-19. This drug is a combination of antibodies derived from humanized VelocImmune® mice in addition to blood samples from patients who have recovered from COVID-19. These antibodies have been formulated to...
Approved
Experimental
Matched Description: … [L23524] In November 2021, the same indication was approved by the EMA. ... investigational recombinant human IgG1 monoclonal antibodies that, at this time, are not officially approved …
Matched Categories: … Approved Treatments for COVID-19 …

Entecavir

Entecavir is an oral antiviral drug used in the treatment of hepatitis B infection. It is marketed under the trade name Baraclude (BMS). Entecavir is a guanine analogue that inhibits all three steps in the viral replication process, and the manufacturer claims that it is more efficacious than previous agents...
Approved
Investigational
Matched Description: … It was approved by the U.S. Food and Drug Administration (FDA) in March 2005. ... the viral replication process, and the manufacturer claims that it is more efficacious than previous agents …
Matched Categories: … Antiviral Agents ... Anti-Infective Agents …
Matched Products: … Truemed Group LLC …

Technetium Tc-99m oxidronate

Technetium Tc-99m oxidronate, also known as 99mTc-methylene diphosphonate, is a radiopharmaceutical agent. A radiopharmaceutical is defined as a medicinal formulation containing radioisotopes that are used in major clinical areas for diagnosis and/or therapy. The radiopharmaceuticals based on technetium-99m are widely used for diagnostic purposes because 99mTc has a versatile chemistry...
Approved
Matched Description: … The group oxidronate falls into the category of diphosphonates whose structure allows them to bind to ... [L1140] It was developed by Mallinkrodt nuclear and FDA approved on February 18, 1981. …

Clenbuterol

A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
Approved
Investigational
Vet approved
Matched Categories: … Adrenergic Agents ... Autonomic Agents ... Anti-Asthmatic Agents ... Bronchodilator Agents ... Neurotransmitter Agents …

Dicloxacillin

One of the penicillins which is resistant to penicillinase.
Approved
Investigational
Vet approved
Matched Categories: … Anti-Bacterial Agents ... Anti-Infective Agents …
Matched Products: … Truemed Group LLC …

Mineral oil

Mineral oil, or paraffin oil, is a mixture of higher alkanes from a mineral source, such as petroleum. Petroleum mineral oil is manufactured from crude oils by vacuum distillation to produce several distillates and a residual oil that are then further refined. During the modern refining process, aromatics are reduced...
Approved
Vet approved
Matched Description: … Unrefined or mildly treated mineral oils are classified as Group 3 carcinogens by the World Health Organizations …
Matched Products: … Canadian National Pharma Group Inc Mineral Oil Heavy USP …
Displaying drugs 1 - 25 of 8596 in total